Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.046 | 0.7 |
mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.053 | 0.7 |
mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |